学术探索
学术期刊
新闻热点
数据分析
智能评审

Choosing the source of stem cells for allogeneic transplantation: No longer a peripheral issue

被引：25
作者：
Appelbaum, FR
机构：
[1] Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA
[2] Univ Washington, Sch Med, Seattle, WA 98195 USA
来源：
BLOOD | 1999年 / 94卷 / 02期
关键词：
D O I：
10.1182/blood.V94.2.381.414a48_381_383
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：381 / 383
页数：3
相关论文
共 15 条
  • [1] Arpinati M, 1998, BLOOD, V92, p111A
  • [2] TRANSPLANTATION OF ALLOGENEIC PERIPHERAL-BLOOD STEM-CELLS MOBILIZED BY RECOMBINANT HUMAN GRANULOCYTE-COLONY-STIMULATING FACTOR
    BENSINGER, WI
    WEAVER, CH
    APPELBAUM, FR
    ROWLEY, S
    DEMIRER, T
    SANDERS, J
    STORB, R
    BUCKNER, CD
    [J]. BLOOD, 1995, 85 (06) : 1655 - 1658
  • [3] Allogeneic peripheral blood stem cell transplantation in patients with advanced hematologic malignancies: A retrospective comparison with marrow transplantation
    Bensinger, WI
    Clift, R
    Martin, P
    Appelbaum, FR
    Demirer, T
    Gooley, T
    Lilleby, K
    Rowley, S
    Sanders, J
    Storb, R
    Buckner, CD
    [J]. BLOOD, 1996, 88 (07) : 2794 - 2800
  • [4] Champlin R, 1998, BLOOD, V92, p657A
  • [5] Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation
    Collins, RH
    Shpilberg, O
    Drobyski, WR
    Porter, DL
    Giralt, S
    Champlin, R
    Goodman, SA
    Wolff, SN
    Hu, W
    Verfaillie, C
    List, A
    Dalton, W
    Ognoskie, N
    Chetrit, A
    Antin, JH
    Nemunaitis, J
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1997, 15 (02) : 433 - 444
  • [6] The risk of residual molecular and cytogenetic disease in patients with Philadelphia-chromosome positive first chronic phase chronic myelogenous leukemia is reduced after transplantation of allogeneic peripheral blood stem cells compared with bone marrow
    Elmaagacli, AH
    Beelen, DW
    Opalka, B
    Seeber, S
    Schaefer, UW
    [J]. BLOOD, 1999, 94 (02) : 384 - 389
  • [7] ALLOGENEIC BLOOD STEM-CELL TRANSPLANTATION FOR REFRACTORY LEUKEMIA AND LYMPHOMA - POTENTIAL ADVANTAGE OF BLOOD OVER MARROW ALLOGRAFTS
    KORBLING, M
    PRZEPIORKA, D
    HUH, YO
    ENGEL, H
    VANBESIEN, K
    GIRALT, S
    ANDERSSON, B
    KLEINE, HD
    SEONG, D
    DEISSEROTH, AB
    ANDREEFF, M
    CHAMPLIN, R
    [J]. BLOOD, 1995, 85 (06) : 1659 - 1665
  • [8] PRETREATMENT OF DONOR MICE WITH GRANULOCYTE-COLONY-STIMULATING FACTOR POLARIZES DONOR T-LYMPHOCYTES TOWARD TYPE-2 CYTOKINE PRODUCTION AND REDUCES SEVERITY OF EXPERIMENTAL GRAFT-VERSUS-HOST DISEASE
    PAN, LY
    DELMONTE, J
    JALONEN, CK
    FERRARA, JLM
    [J]. BLOOD, 1995, 86 (12) : 4422 - 4429
  • [9] Allogeneic blood stem cell transplantation in advanced hematologic cancers
    Przepiorka, D
    Anderlini, P
    Ippoliti, C
    Khouri, I
    Fietz, T
    Thall, P
    Mehra, R
    Giralt, S
    Gajewski, J
    Deisseroth, AB
    Cleary, K
    Champlin, R
    vanBesien, K
    Andersson, B
    Korbling, M
    [J]. BONE MARROW TRANSPLANTATION, 1997, 19 (05) : 455 - 460
  • [10] PRIMARY TRANSPLANTATION OF ALLOGENEIC PERIPHERAL-BLOOD PROGENITOR CELLS MOBILIZED BY FILGRASTIM (GRANULOCYTE-COLONY-STIMULATING FACTOR)
    SCHMITZ, N
    DREGER, P
    SUTTORP, M
    ROHWEDDER, EB
    HAFERLACH, T
    LOFFLER, H
    HUNTER, A
    RUSSELL, NH
    [J]. BLOOD, 1995, 85 (06) : 1666 - 1672
12